Abbott to Present at Wells Fargo Securities Research & Economics 2013 Healthcare Conference

ABBOTT PARK, Ill., June 10, 2013 /PRNewswire/ -- Abbott (NYSE: ABT) will present at the Wells Fargo Securities Research & Economics 2013 Healthcare Conference on Wednesday, June 19, 2013. Thomas C. Freyman, executive vice president, finance and chief financial officer, will participate in a 30-minute question and answer session regarding the company beginning at 9:05 a.m. Central time.

A live audio webcast of the presentation will be accessible through Abbott's Investor Relations Web site at An archived edition of the presentation will be available later that day.

About Abbott

Abbott is a global healthcare company devoted to improving life through the development of products and technologies that span the breadth of healthcare. With a portfolio of leading, science-based offerings in diagnostics, medical devices, nutritionals and branded generic pharmaceuticals, Abbott serves people in more than 150 countries and employs approximately 70,000 people.

Visit Abbott at and connect with us on Twitter at @AbbottNews.


Suggested Articles

The phase 2/3 clinical trial linked REGN-COV2 to a 57% decline in medical visits associated with COVID-19 in the 29 days after treatment.

Drug companies often face steep challenges when entering new markets for the first time. LianBio is here to help.

Novartis is picking up Vedere Bio and its preclinical gene therapies for $150 million upfront, with the promise of another $130 million.